Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Moderna, Takeda Gain as Findings Say Japan Deaths Not Linked To Vaccine

Published 09/01/2021, 09:22 AM
Updated 09/01/2021, 09:25 AM
© Reuters

By Dhirendra Tripathi

Investing.com – Moderna stock (NASDAQ:MRNA) and Takeda ADRs (NYSE:TAK) rose around 1.5% each after the two companies jointly said they had found no evidence that the two recent deaths in Japan were linked to the Covid-19 vaccine made by the former.

Takeda Pharmaceutical is the distributor of the vaccine in Japan.

Two men died last month after receiving their second dose. The two companies conducted a review that showed “the rare presence of stainless steel particles in the vaccine.” However, the presence “does not pose an undue risk to patient safety and it does not adversely affect the benefit/risk profile of the product,” they said.

The stainless steel element, classified as grade 316, is a high quality alloy used in manufacturing, food processing and several implants.

The findings come two days after Japanese authorities suspended as many as 2.6 million doses of Moderna's mRNA vaccine due to contamination in some batches.

Latest comments

It's amazing how one PR can make a vaccine guilty before getting all the fact across.  So easy to rush to judgement.  Something tells me a large hedge fund shorting MRNA was in the shadow then taking profits the next day of the so called contamination.  We don't know both sides of the story but something tells me its corrupted.
🤣🤣🤣 of course they aren't.. why would they say anything less. they'll just blame the "unvaccinated"
wtever, these companies deny. so why they know the solution.
that's probably that chip only nobody can verify yet... :/
lies lies now they made superman steel power, so we need to said thankyou
Of course it did.
what do you know, believer?
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.